athenahealth Names Tom Cowhey Chief Financial Officer
BOSTON, May 27, 2025--(BUSINESS WIRE)--athenahealth, a leading provider of network-enabled software and services for healthcare practices nationwide, today announced the appointment of Tom Cowhey as the company's new chief financial officer, effective June 9, 2025.
Cowhey brings more than two decades of experience leading financial organizations for large, innovative care delivery organizations. He most recently served as Executive Vice President and Chief Financial Officer at CVS Health, where he was also a member of the investment committee for CVS Health Ventures. Prior to his time at CVS Health, Cowhey was the CFO at Surgery Partners, the largest independent operator of short-stay and ambulatory surgical facilities in the United States. From 2007 to 2018, Cowhey held various positions at Aetna, including as CFO of Aetna's U.S. health plan business.
"Tom Cowhey brings a broad industry perspective, a deep understanding of the ambulatory care landscape, and first-hand knowledge of the value and impact of the athenahealth platform," said Bob Segert, chairman and chief executive officer at athenahealth. "His ability to integrate the customer perspective into his work will make him an ideal addition to our executive team, and his expertise managing key stakeholders will ensure the market understands our vision, strategy, and execution across athenahealth's lines of business."
While at Surgery Partners, Cowhey participated in evaluating and implementing athenaOne, recognizing the platform's impact in reducing complexity and revenue cycle improvement.
"I've long admired athenahealth for its mission to transform healthcare delivery for the ambulatory care market, and the leadership team's ability to execute on its strategy," said Cowhey. "I share the belief that the future of care will be delivered in settings that prioritize accessible, high-quality, and sustainable care, and I look forward to partnering with this exceptional leadership team to realize those ambitions and drive the next phase of growth for athenahealth."
Tom Cowhey holds a B.A. in economics from Wesleyan University and an M.B.A. from Duke University with a concentration in health sector management.
About athenahealth, Inc.
athenahealth strives to cure complexity and simplify the practice of healthcare. Our innovative technology includes electronic health records, revenue cycle management, and patient engagement solutions that help healthcare providers, administrators, and practices eliminate friction for patients while getting paid efficiently. athenahealth partners with practices with purpose-built software backed by expertise to produce the insights needed to drive better clinical and financial outcomes. We're inspired by our vision to create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all. Learn more at athenahealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527611752/en/
Contacts
Iz ConroyMedia@athenahealth.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
CVS Headlines $18 Billion High-Grade Bond Blitz Before CPI
(Bloomberg) -- CVS Health Corp. and a unit of Chevron Corp. are among 14 firms raising $17.65 billion of US investment-grade bonds Monday, the most deals in three months, as issuers rush to market ahead of this week's anticipated consumer-price data. Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion New York Warns of $34 Billion Budget Hole, Biggest Since 2009 Crisis To Head Off Severe Storm Surges, Nova Scotia Invests in 'Living Shorelines' Chicago Schools' Bond Penalty Widens as $734 Million Gap Looms A New Stage for the Theater That Gave America Shakespeare in the Park The deals follow $40.4 billion of high-grade issuance last week, that saw the highest volume since May, as average yields for investment-grade corporates reached their lowest level of 2025 and premiums are near their tightest in a quarter-century. Selling debt now avoids potential interest-rate volatility following Tuesday's consumer-price report. Chevron USA Inc. is marketing $5.5 billion of bonds in seven tranches, six months after completing a similar deal that raised $5.5 billion. Meanwhile, CVS is holding its first investment-grade sale of 2025. Proceeds will in part repay existing debt, according to a person familiar with the matter. The longest portion of the four-part transaction is a 40-year security that will yield 1.42 percentage points above Treasuries after initially discussing around 1.7 percentage points, said the person, who asked not to be identified as the details are private. The company sold $3 billion of hybrid bonds last December and $5 billion of notes in May 2024. Wall Street syndicate desks had projected $40 billion to $45 billion of high-grade bond sales for this week. Activity should 'remain healthy' until the typical lull arrives in late-August, said Kyle Stegemeyer, head of investment-grade debt capital markets and syndicate at U.S. Bank. Bloomberg Economics expects consumer-price data for July to show inflation having accelerated from previous months, with price gains in core goods and services both anticipated to have picked up. The reports for July and August will be key for the Federal Reserve's next policy meeting in September, when markets are starting to price in the first interest rate cut of 2025. (Updates through out with sales volume, launch details) Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Social Media Trend Machine Is Spitting Out Weirder and Weirder Results Klarna Cashed In on 'Buy Now, Pay Later.' Now It Wants to Be a Bank The Game Starts at 8. The Robbery Starts at 8:01 It's Only a Matter of Time Until Americans Pay for Trump's Tariffs ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
CVS Among 14 Firms to Storm High-Grade Market Before CPI Report
(Bloomberg) -- CVS Health Corp. and a unit of Chevron Corp. are among 14 firms offering US investment-grade bonds Monday, the most in three months, a day before heavily anticipated consumer-price data is due for release. Sunseeking Germans Face Swiss Backlash Over Alpine Holiday Congestion New York Warns of $34 Billion Budget Hole, Biggest Since 2009 Crisis Three Deaths Reported as NYC Legionnaires' Outbreak Spreads Chicago Schools' Bond Penalty Widens as $734 Million Gap Looms A New Stage for the Theater That Gave America Shakespeare in the Park The deals follow $40.4 billion of high-grade issuance last week, also the highest since May, as average yields for investment-grade corporates reached their lowest level of 2025 and premiums are near their tightest in a quarter-century. Selling debt now avoids potential interest-rate volatility following Tuesday's consumer-price report. Chevron USA Inc. is marketing bonds in as many as seven tranches, six months after completing a similar deal that raised $5.5 billion. Meanwhile, CVS is holding its first investment-grade sale of 2025. Proceeds will in part repay existing debt, according to a person familiar with the matter. The longest portion of the four-part transaction is a 40-year security that may yield 1.7 percentage points above Treasuries, said the person, who asked not to be identified as the details are private. The company sold $3 billion of hybrid bonds last December and $5 billion of notes in May 2024. Wall Street syndicate desks had projected $40 billion to $45 billion of high-grade bond sales for this week. Activity should 'remain healthy' until the typical late-August lull occurs, said Kyle Stegemeyer, head of investment-grade debt capital markets and syndicate at U.S. Bank. Bloomberg Economics expects consumer-price data for July to show inflation having accelerated from previous months, with price gains in core goods and services both anticipated to have picked up. The reports for July and August will be key for the Federal Reserve's next policy meeting in September, when the first interest rate cut of 2025 could occur. Why It's Actually a Good Time to Buy a House, According to a Zillow Economist The Game Starts at 8. The Robbery Starts at 8:01 Klarna Cashed In on 'Buy Now, Pay Later.' Now It Wants to Be a Bank The Pizza Oven Startup With a Plan to Own Every Piece of the Pie Digital Nomads Are Transforming Medellín's Housing ©2025 Bloomberg L.P. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Bloomberg
8 hours ago
- Bloomberg
CVS Among 14 Firms to Storm High-Grade Market Before CPI Report
CVS Health Corp. and a unit of Chevron Corp. are among 14 firms offering US investment-grade bonds Monday, the most in three months, a day before heavily anticipated consumer-price data is due for release. The deals follow $40.4 billion of high-grade issuance last week, also the highest since May, as average yields for investment-grade corporates reached their lowest level of 2025 and premiums are near their tightest in a quarter-century. Selling debt now avoids potential interest-rate volatility following Tuesday's consumer-price report.
